Concepedia

Fallon Lin

FL

11

Publications

1.4K

Citations

11

H-Index

1965

Active since

Affiliations

Novartis (United States)(Current)

Dana-Farber Cancer Institute

Novartis (China)

Novartis Institutes for BioMedical Research

Novartis (Switzerland)

Fallon Lin is an author at Novartis (United States) specializing in medicine, signal transduction, and tumor biology.

Top concepts

Publications per year

1965–2020

11

Publications

11

Disordered methionine metabolism in MTAP/CDKN2A-deleted cancers leads to dependence on PRMT5

Konstantinos J. Mavrakis, E. Robert McDonald, Michael R. Schlabach et al. · Science · 2016 · 538 citations

IDH1 Mutations Alter Citric Acid Cycle Metabolism and Increase Dependence on Oxidative Mitochondrial Metabolism

Alexandra Grassian, Seth J. Parker, Shawn M. Davidson et al. · Cancer Research · 2014 · 285 citations · Full text

Isocitrate Dehydrogenase (IDH) Mutations Promote a Reversible ZEB1/MicroRNA (miR)-200-dependent Epithelial-Mesenchymal Transition (EMT)

Alexandra Grassian, Fallon Lin, Rosemary Barrett et al. · Journal of Biological Chemistry · 2012 · 136 citations · Full text

IDH1 Mutations Alter Citric Acid Cycle Metabolism and Increase Dependence on Oxidative Mitochondrial Metabolism

Alexandra Grassian, Seth J. Parker, Ajit S. Divakaruni et al. · DSpace@MIT (Massachusetts Institute of Technology) · 2014 · 94 citations · Full text

ERG signaling in prostate cancer is driven through PRMT5-dependent methylation of the Androgen Receptor

Zineb Mounir, Joshua M. Korn, Thomas Westerling et al. · eLife · 2016 · 73 citations · Full text

Rows per page

1–5 of 11